Project Veritas released another video tonight in their 5-part series about the covid vaccine. The whistleblower in the video below tells ...
Project Veritas released another video tonight in their 5-part series about the covid vaccine. The whistleblower in the video below tells of a cover-up by Pfizer that they used human fetal tissue in lab testing of the COVID vaccine.
Melissa Strickler leaked internal emails that show corporate executives telling staff to be secretive about using human fetal tissue in laboratory testing of the COVID vaccine.
Strickler says that Pfizer is trying to cover up this information because people who want religious exemptions will have the fetal tissue issue to help get that exemption from getting the COVID vaccine.
The key evidence presented is from emails and documents where Vanessa Gelman and Philip Dormitzer mention human fetal cells “derived from an aborted fetus.”
-Vanessa Gelman, Pfizer Senior Director of Worldwide Research: “From the perspective of corporate affairs, we want to avoid having the information on fetal cells floating out there…The risk of communicating this right now outweighs any potential benefit we could see, particularly with general members of the public who may take this information and use it in ways we may not want out there. We have not received any questions from policymakers or media on this issue in the last few weeks, so we want to avoid raising this if possible.”
-Vanessa Gelman: “We have been trying as much as possible to not mention the fetal cell lines…One or more cell lines with an origin that can be traced back to human fetal tissue has been used in laboratory tests associated with the vaccine program.”
-Philip Dormitzer, Pfizer Chief Scientific Officer: “HEK293T cells, used for the IVE assay, are ultimately derived from an aborted fetus. On the other hand, the Vatican doctrinal committee has confirmed that they consider it acceptable for Pro-Life believers to be immunized. Pfizer’s official statement couches the answer well and is what should be provided in response to an outside inquiry.”
No comments